US FTC: Teva removes over 200 improper patent listings under pressure from FTC
Dec 10 (Reuters) -
Source text: https://tinyurl.com/mpe7u59w
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.